In vivo activity of the combination of daptomycin and fosfomycin compared with daptomycin alone against a strain of Enterococcus faecalis with high-level gentamicin resistance in the rat endocarditis model
- 29 February 1992
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 15 (2) , 173-176
- https://doi.org/10.1016/0732-8893(92)90045-u
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032)Antimicrobial Agents and Chemotherapy, 1990
- Enterococcal Endocarditis: A Comparison of Prosthetic and Native Valve DiseaseClinical Infectious Diseases, 1990
- Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicinAntimicrobial Agents and Chemotherapy, 1989
- In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistanceAntimicrobial Agents and Chemotherapy, 1989
- Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032Antimicrobial Agents and Chemotherapy, 1987
- Continuous-infusion ampicillin therapy of enterococcal endocarditis in ratsAntimicrobial Agents and Chemotherapy, 1987
- In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibioticAntimicrobial Agents and Chemotherapy, 1986
- Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis.Journal of Clinical Investigation, 1983
- Antimicrobial activity of fosfomycin in vitroJournal of Antimicrobial Chemotherapy, 1983
- THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN)Annals of the New York Academy of Sciences, 1974